The Pathological Spectrum of Systemic Anaplastic Large Cell Lymphoma (ALCL)

The Pathological Spectrum of Systemic Anaplastic Large Cell Lymphoma (ALCL)

Anaplastic large cell lymphoma (ALCL) represents a group of malignant T-cell lymphoproliferations that share morphological and immunophenotypical features, namely strong CD30 expression and variable loss of T-cell markers, but differ in clinical presentation and prognosis. The recognition of anaplas...

Full description

Bibliographic Details
Main Authors:	Ivonne A. Montes-Mojarro, Julia Steinhilber, Irina Bonzheim, Leticia Quintanilla-Martinez, Falko Fend
Format:	Article
Language:	English
Published:	MDPI AG 2018-04-01
Series:	Cancers
Subjects:	anaplastic large cell lymphoma (ALCL) ALK (anaplastic lymphoma kinase) breast implant-associated ALCL lymphoma morphology
Online Access:	http://www.mdpi.com/2072-6694/10/4/107

Similar Items

From Pathology to Precision Medicine in Anaplastic Large Cell Lymphoma Expressing Anaplastic Lymphoma Kinase (ALK+ ALCL)
by: Michael T. Werner, et al.
Published: (2017-10-01)

Anaplastic Large Cell Lymphoma: Molecular Pathogenesis and Treatment
by: Xin-Rui Zhang, et al.
Published: (2022-03-01)

Role of ALK Inhibitors in Anaplastic Large Cell Lymphoma—Experience from an Indian Center
by: Muthiah Vaikundaraja Indhuja, et al.

Breast lymphomas, breast implants and capsules The timeline of BIA-ALCL with respect to surgical consent: the UK perspective
by: Keith Allison, et al.
Published: (2022-12-01)

The Dual Role of Autophagy in Crizotinib-Treated ALK<sup>+</sup> ALCL: From the Lymphoma Cells Drug Resistance to Their Demise
by: Estelle Espinos, et al.
Published: (2021-09-01)

ALK signaling and target therapy in anaplastic large cell lymphoma
by: Fabrizio eTabbo, et al.
Published: (2012-05-01)

An Exploration into the Origins and Pathogenesis of Anaplastic Large Cell Lymphoma, Anaplastic Lymphoma Kinase (ALK)-Positive
by: Suzanne D. Turner
Published: (2017-10-01)

18F-FDG PET/CT imaging findings in anaplastic large cell lymphoma, a rare subtype of lymphoma
by: Yanping Jiang, et al.
Published: (2020-01-01)

Immune Response against ALK in Children with ALK-Positive Anaplastic Large Cell Lymphoma
by: Serena Stadler, et al.
Published: (2018-04-01)

Clinical recommendations for diagnosis and treatment according to current updated knowledge on BIA-ALCL
by: Benedetto Longo, et al.
Published: (2022-12-01)

Breast Implant and Anaplastic Large Cell Lymphoma Meta-Analysis
by: Guillermo Ramos-Gallardo, et al.
Published: (2017-01-01)

The State of the Art about Etiopathogenetic Models on Breast Implant Associated–Anaplastic Large Cell Lymphoma (BIA-ALCL): A Narrative Review
by: Roberto Cuomo
Published: (2021-05-01)

Brentuximab vedotin use in pediatric anaplastic large cell lymphoma
by: Jennifer E. Agrusa, et al.
Published: (2023-05-01)

Anaplastic large cell lymphoma: A great mimic on cytology
by: Mona A Agnihotri, et al.
Published: (2017-01-01)

Anaplastic lymphoma kinase negative anaplastic large cell lymphoma of hard palate as first clinical manifestation of acquired immune deficiency syndrome
by: Anjali Narwal, et al.
Published: (2016-01-01)

First Case Report of Breast Implant Associated-Anaplastic Large Cell Lymphoma from India: Are We Ready?
by: Soumya Khanna, et al.
Published: (2023-04-01)

A case of tonsillar anaplastic large cell lymphoma-anaplastic lymphoma kinase negative: An unusual site of involvement with review of literature
by: Umesh Das, et al.
Published: (2014-01-01)

Breast implant-associated anaplastic large cell lymphoma in a Li-FRAUMENI patient: a case report
by: Ricardo Garcia Pastorello, et al.
Published: (2018-01-01)

Holistic View of ALK TKI Resistance in ALK-Positive Anaplastic Large Cell Lymphoma
by: Yuan Wang, et al.
Published: (2022-02-01)

CD30, CD15, CD50, and PAX5 Expressions as Diagnostic Markers for Hodgkin Lymphoma (HL) and Systemic Anaplastic Large Cell Lymphoma (sALCL)
by: Dody Ranuhardy, et al.
Published: (2018-06-01)

Anaplastic Lymphoma Kinase in Cutaneous Malignancies
by: Severine Cao, et al.
Published: (2017-09-01)

Three years sustained complete remission achieved in a primary refractory ALK-positive anaplastic T large cell lymphoma treated with crizotinib
by: Carolina Valeria Mahuad, et al.
Published: (2016-06-01)

Story of survival in anaplastic large cell lymphoma - sometimes more than the anaplastic lymphoma kinase status: An evaluation of pathologic prognostic factors in 102 cases
by: Komal Agrawal, et al.
Published: (2017-01-01)

Anaplastic large T-cell lymphoma: 10-year experience at the National Institute of Neoplastic Diseases, Lima – Peru
by: Cristian Pacheco, et al.
Published: (2022-07-01)

Anaplastic lymphoma kinase–positive anaplastic large cell lymphoma presenting as diffuse pulmonary infiltrates
by: Shuku Sato, et al.
Published: (2020-10-01)

Tumor Resistance against ALK Targeted Therapy-Where It Comes From and Where It Goes
by: Geeta Geeta Sharma, et al.
Published: (2018-02-01)

Granulomatous Inflammation in a Patient with ALK-Negative Anaplastic Large Cell Lymphoma
by: Özlem Kandemir Alibakan, et al.
Published: (2022-02-01)

Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma diagnosed in a 90-year-old Japanese woman with simultaneous rearrangements of T-cell receptor and immunoglobulin genes: A case report
by: Kenji Yorita, et al.
Published: (2023-09-01)

Cardiac anaplastic large cell lymphoma in an 8-year old boy
by: Melchior Lauten, et al.
Published: (2014-01-01)

Recurrent systemic anaplastic large cell lymphoma: Rapid onset and resolution of cutaneous metastases
by: Jun Long, PhD, et al.
Published: (2020-02-01)

Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma with Cardiac Metastasis and Arterial Tumor Embolisms during First-Course Chemotherapy
by: Kozo Nagai, et al.
Published: (2016-08-01)

ALK+ Anaplastic large cell lymphoma with extensive cardiac involvement: A rare case report and review of the literature
by: Kaniyappan Nambiyar, et al.
Published: (2021-01-01)

MOLECULAR BIOLOGICAL CHARACTERISTICS OF ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA
by: E. V. Chernyshova, et al.
Published: (2017-01-01)

Analysis of Histologic Features Suspecting Anaplastic Lymphoma Kinase (ALK)-Expressing Pulmonary Adenocarcinoma
by: In Ho Choi, et al.
Published: (2015-07-01)

A Severe Case of Anaplastic Large Cell Lymphoma in a Previously Healthy Woman: Diagnostic and Therapeutic Challenges
by: Petya Angelova, et al.
Published: (2020-12-01)

Anaplastic Lymphoma Kinase- and CD30-Positive Anaplastic Large-Cell Lymphoma of the External Auditory Canal
by: Shih-Lung Chen, et al.
Published: (2021-07-01)

ALK+ Anaplastic Large Cell Lymphoma of Null Cell Phenotype with Leukemic Transformation and Leukemoid Reaction
by: Shih-Sung Chuang, et al.
Published: (2019-11-01)

A Case of Anaplastic Lymphoma Kinase-positive Large B-cell Lymphoma
by: Gaurav Gupta, et al.
Published: (2019-08-01)

A case of primary central nervous system anaplastic lymphoma kinase-positive anaplastic large cell lymphoma in the neurohypophysis and pineal gland
by: Ryo Omae, et al.
Published: (2022-12-01)

Diagnostic Capability of Next-Generation Sequencing Fusion Analysis in Identifying a Rare CASE of TRAF1-ALK-Associated Anaplastic Large Cell Lymphoma
by: Indu Agarwal, et al.
Published: (2020-05-01)